Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

554 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pre-procedural oral anticoagulant use is associated with cardiovascular events in women after transcatheter aortic valve replacement: An analysis from the WIN-TAVI cohort.
van Bergeijk KH, Wykrzykowska JJ, Sartori S, Snyder C, Vogel B, Tchetche D, Petronio AS, Mehilli J, Lefèvre T, Presbitero P, Capranzano P, Iadanza A, Sardella G, Van Mieghem NM, Meliga E, Dumonteil N, Fraccaro C, Trabattoni D, Mikhail G, Ferrer-Gracia MC, Naber C, Kievit P, Sharma SK, Morice MC, Dangas GD, Chieffo A, Voors AA, Mehran R. van Bergeijk KH, et al. Among authors: chieffo a. Int J Cardiol. 2023 Feb 1;372:40-45. doi: 10.1016/j.ijcard.2022.11.056. Epub 2022 Nov 28. Int J Cardiol. 2023. PMID: 36455701
17-beta-estradiol eluting stent versus phosphorylcholine-coated stent for the treatment of native coronary artery disease.
Airoldi F, Di Mario C, Ribichini F, Presbitero P, Sganzerla P, Ferrero V, Vassanelli C, Briguori C, Carlino M, Montorfano M, Biondi-Zoccai GG, Chieffo A, Ferrari A, Colombo A. Airoldi F, et al. Among authors: chieffo a. Am J Cardiol. 2005 Sep 1;96(5):664-7. doi: 10.1016/j.amjcard.2005.04.040. Am J Cardiol. 2005. PMID: 16125491 Clinical Trial.
Longest available clinical outcomes after drug-eluting stent implantation for unprotected left main coronary artery disease: the DELFT (Drug Eluting stent for LeFT main) Registry.
Meliga E, Garcia-Garcia HM, Valgimigli M, Chieffo A, Biondi-Zoccai G, Maree AO, Cook S, Reardon L, Moretti C, De Servi S, Palacios IF, Windecker S, Colombo A, van Domburg R, Sheiban I, Serruys PW; DELFT (Drug Eluting stent for LeFT main) Registry. Meliga E, et al. Among authors: chieffo a. J Am Coll Cardiol. 2008 Jun 10;51(23):2212-9. doi: 10.1016/j.jacc.2008.03.020. J Am Coll Cardiol. 2008. PMID: 18534266 Free article.
Diabetic patients treated for unprotected left main coronary artery disease with drug eluting stents: a 3-year clinical outcome study. The diabetes and drug eluting stent for LeFT main registry (D-DELFT).
Meliga E, Garcia-Garcia HM, Valgimigli M, Chieffo A, Biondi-Zoccai G, Maree AO, Gonzalo N, Cook S, Cruz-Gonzalez I, Marra S, De Servi S, Palacios IF, Windecker S, van Domburg R, Colombo A, Sheiban I, Serruys PW. Meliga E, et al. Among authors: chieffo a. EuroIntervention. 2008 May;4(1):77-83. doi: 10.4244/eijv4i1a14. EuroIntervention. 2008. PMID: 19112783
554 results